Context Therapeutics Inc.
CNTX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$26,725 | -$23,964 | -$14,836 | -$10,457 |
| Dep. & Amort. | $11 | $12 | $9 | $0 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $842 | $1,077 | $0 | $511 |
| Change in WC | -$3,476 | $1,776 | -$278 | -$2,225 |
| Other Non-Cash | $14,792 | $52 | $1,555 | $3,371 |
| Operating Cash Flow | -$14,556 | -$21,048 | -$13,549 | -$8,799 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$7 | $0 | -$537 | -$250 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | -$14,750 | $0 | $0 | $0 |
| Investing Cash Flow | -$14,757 | $0 | -$537 | -$250 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $109,294 | $0 | -$102 | $53,411 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $0 | $4,983 |
| Financing Cash Flow | $109,294 | $0 | -$102 | $58,394 |
| Forex Effect | $0 | $0 | $50 | $0 |
| Net Chg. in Cash | $79,980 | -$21,048 | -$14,138 | $49,345 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $14,450 | $35,497 | $49,635 | $341 |
| End Cash | $94,430 | $14,450 | $35,497 | $49,686 |
| Free Cash Flow | -$29,314 | -$21,048 | -$14,086 | -$9,049 |